Atezolizumab Monotherapy Beneficial for NSCLC Ineligible for Platinum-Based Chemo
TUESDAY, Aug. 15, 2023 (HealthDay News) — For patients with non-small cell lung cancer (NSCLC) ineligible for platinum-based chemotherapy, first-line atezolizumab monotherapy is associated with improved overall survival compared to single-agent chemo…
Learn MoreFindings of IDEA Collaboration Have Influenced Prescribing Patterns
WEDNESDAY, Aug. 9, 2023 (HealthDay News) — Changes in prescribing patterns for resected stage III colon cancer have been observed since the abstract presentation of the IDEA collaboration in June 2017, according to a study published online Aug. 7 in …
Learn MoreAerobic Exercise Might Ease Pain for Women Who’ve Survived Ovarian Cancer
WEDNESDAY, Aug. 9, 2023 (HealthDay News) — Patients being treated for ovarian cancer often experience peripheral neuropathy, a side effect from their chemotherapy that can cause both pain and numbness for months, or even years.Now, a new study sugges…
Learn MoreAerobic Exercise Might Ease Pain for Women Who’ve Survived Ovarian Cancer
WEDNESDAY, Aug. 9, 2023 (HealthDay News) — Patients being treated for ovarian cancer often experience peripheral neuropathy, a side effect from their chemotherapy that can cause both pain and numbness for months, or even years.Now, a new study sugges…
Learn MoreAerobic Exercise Cuts Chemotherapy-Induced Peripheral Neuropathy Symptoms
WEDNESDAY, Aug. 2, 2023 (HealthDay News) — A six-month aerobic exercise intervention significantly improves self-reported chemotherapy-induced peripheral neuropathy (CIPN) among patients treated for ovarian cancer, according to a study published onli…
Learn MoreNew Type of Treatment Tackles Tough-to-Treat Prostate Cancer
THURSDAY, July 13, 2023 (HealthDay News) — A preclinical study offers a potential new therapy for treatment-resistant prostate cancer, offering new hope for men with the disease.The study used the chemotherapy drug cisplatin, administered orally, to …
Learn MoreChemotherapy-Induced Pseudocellulitis Described in Case Reports
WEDNESDAY, July 5, 2023 (HealthDay News) — Chemotherapy-induced adverse cutaneous drug reactions that mimic cellulitis, including those termed pseudocellulitis, do not meet criteria for other diagnoses, according to a review published online June 28 …
Learn MoreOverweight Tied to Better Head, Neck Cancer Outcomes After Chemoradiotherapy
FRIDAY, June 30, 2023 (HealthDay News) — Overweight body mass index (BMI) is associated with favorable outcomes in patients with nonmetastatic head and neck cancer undergoing chemoradiotherapy, according to a study published online June 27 in JAMA Ne…
Learn MoreASCO: FOLFOX Noninferior to Chemoradiotherapy for Overall Survival in Rectal Cancer
FRIDAY, June 9, 2023 (HealthDay News) — Neoadjuvant chemotherapy with fluorouracil, leucovorin, and oxaliplatin (FOLFOX) is noninferior to preoperative chemoradiotherapy with respect to overall survival for patients with locally advanced rectal cance…
Learn MoreMany Cancer Centers Experiencing Shortage of Carboplatin, Cisplatin
THURSDAY, June 8, 2023 (HealthDay News) — Ninety-three and 70 percent of cancer centers are currently experiencing a shortage of carboplatin and cisplatin, respectively, according to a report published June 7 by the National Comprehensive Cancer Netw…
Learn More